An Ex Vivo Evaluation of Cenobamate Administered via Enteral Tubes

BACKGROUND: Cenobamate is a new, Food and Drug Administration (FDA)-approved oral antiepileptic drug for treatment of focal seizures in adults. This study examined recovery of cenobamate from suspensions administered through ex vivo enteral feeding tubes. METHODS: Suspensions containing 100 and 200 ...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrari, Louis, Nisman, Arkady, Pegan, Augustin, Ursino, Jordan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221039/
https://www.ncbi.nlm.nih.gov/pubmed/32328931
http://dx.doi.org/10.1007/s40268-020-00305-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221039/
https://www.ncbi.nlm.nih.gov/pubmed/32328931
http://dx.doi.org/10.1007/s40268-020-00305-4

Ejemplares similares